COVID-19 Induced Pancytopenia in a Major Molecular Response CML patient on Dasatinib: A Case Report and Review of Literature | Zendy

Balraj Singh | Zendy; Sarah Ayad | Zendy; Parminder Kaur | Zendy; Vinod Kumar | Zendy; Sachin Kumar Gupta | Zendy; Michael Maroules | Zendy

Open Access

COVID-19 Induced Pancytopenia in a Major Molecular Response CML patient on Dasatinib: A Case Report and Review of Literature

Author(s) -

Balraj Singh,

Sarah Ayad,

Parminder Kaur,

Vinod Kumar,

Sachin Kumar Gupta,

Michael Maroules

Publication year - 2021

Publication title -

european journal of case reports in internal medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.125

H-Index - 1

ISSN - 2284-2594

DOI - 10.12890/2021_002233

Subject(s) - pancytopenia , medicine , covid-19 , dasatinib , disease , coronavirus , pediatrics , intensive care medicine , infectious disease (medical specialty) , virology , imatinib , outbreak , bone marrow , myeloid leukemia

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has caused a global health crisis. COVID-19 can have a multifaceted presentation. A wide range of complications and outcomes can emerge based on the severity and comorbidities of the infected patient. We report a 42-year-old male with past medical history of CML on Dasatinib (in Major Molecular Response) who was diagnosed with COVID-19 and developed pancytopenia. Our case and review of available reports add to the limited literature available regarding COVID-19 in CML.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research